University of Missouri-Kansas City School of Medicine Advanced Heart Failure and Transplant Cardiology

Topics

• Amyloidosis: Diagnosis, Treatment, Outcomes 71
• Mechanical Circulatory Support Devices 61
• Heart Failure Treatment and Management 58
• Diabetes Treatment and Management 36
• Transplantation: Methods and Outcomes 34
• Cardiac Imaging and Diagnostics 29
• Cardiomyopathy and Myosin Studies 26
• Cardiovascular Function and Risk Factors 21
• Cardiac pacing and defibrillation studies 19
• Atrial Fibrillation Management and Outcomes 11
• Cardiovascular and exercise physiology 11
• Cardiac electrophysiology and arrhythmias 10

Most cited

1. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.

   Nature medicine · 2022 · 758 citations · Michael Nassif

2. Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.

   The New England journal of medicine · 2024 · 266 citations · Michael Nassif

3. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

   Nature medicine · 2021 · 504 citations · Michael Nassif, Taiyeb Khumri

4. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.

   Lancet (London, England) · 2021 · 356 citations · Andrew Sauer

5. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.

   European heart journal · 2023 · 192 citations · Michael Nassif

6. The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.

   Nature medicine · 2022 · 214 citations · Michael Nassif